RADICAVA ORS

Mitsubishi Tanabe Pharma Corporation

Application Filed: 2021-03-22

Trademark Application Details

Mark For: RADICAVA ORS® trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of central nervous system diseases; Pharmaceutical preparations for protection against free radicals; Pharmaceutical preparations for removing free radicals from the human bodies; Neuroprotective medicines; Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS). [all]

Status

2022-02-10 UTC

LIVE APPLICATION Published for Opposition

A pending trademark application has been examined by the Office and has been published in a way that provides an opportunity for the public to oppose its registration.

Research	OneLook Acronym Finder
Serial Number	90594021
Registration Number	6908091
Mark Literal Elements	RADICAVA ORS
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	INTENT TO USE SECTION 2022-01-25
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	005: Adhesives 006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Domestic Representative	Jeffrey Costellia
Attorney Name	Jeffrey Costellia
Attorney Docket Number	740630-234

Timeline

2021-03-22	Application Filed
2021-03-25	Location: NEW APPLICATION PROCESSING
2021-03-25	Status: Live/Pending
2021-03-25	Transaction Date
2021-11-30	Published
2022-01-25	Location: INTENT TO USE SECTION
2022-01-25	Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six
2022-11-22	Trademark Registered

Trademark Parties (Applicants & Owners)

Party:	Mitsubishi Tanabe Pharma Corporation
Address	3-2-10, Dosho-machi Chuo-ku, Osaka-shi Osaka JAPAN 541-8505
Legal Entity Type	Corporation
Legal Entity State	JAPAN

Documents

Application		2021-03-22
Drawing		2021-03-22
Notation to File		2021-10-26
XSearch Search Summary		2021-10-26
TRAM Snapshot of App at Pub for Oppostn		2021-10-27
Notice of Publication		2021-11-10
Notification Of Notice of Publication		2021-11-10
OG Publication Confirmation		2021-11-30
Notice of Allowance		2022-01-25

Attorney of Record

JEFFREY COSTELLIA
NIXON PEABODY LLP
799 9TH STREET, NW, SUITE 500
WASHINGTON, DC 20001

Good, Services, and Codes

IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of central nervous system diseases; Pharmaceutical preparations for protection against free radicals; Pharmaceutical preparations for removing free radicals from the human bodies; Neuroprotective medicines; Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)

International Codes:	5
U.S. Codes:	005,006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations for the treatment of central nervous system diseases; Pharmaceutical preparations for protection against free radicals; Pharmaceutical preparations for removing free radicals from the human bodies; Neuroprotective medicines; Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)
GS0051	Pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; neuroprotective medicines; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)

Trademark Filing History

Description	Date	Proceeding Number
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2022-01-25
PUBLISHED FOR OPPOSITION	2021-11-30
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2021-11-30
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2021-11-10
ASSIGNED TO EXAMINER	2021-10-26	93937
APPROVED FOR PUB - PRINCIPAL REGISTER	2021-10-26
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2021-06-25
NEW APPLICATION ENTERED IN TRAM	2021-03-25

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
RADICAVA ORS 90594021 not registered Live/Pending	Mitsubishi Tanabe Pharma Corporation 2021-03-22
RADICAVA ORS 79298102 not registered Live/Pending	Mitsubishi Tanabe Pharma Corporation 2020-09-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.